PURPOSE OF REVIEW: We examine the interplay between the HIV and COVID-19 epidemics, including the impact of HIV on COVID-19 susceptibility and severe disease, the effect of the COVID-19 epidemic on HIV prevention and treatment, and the influence of the HIV epidemic on responses to COVID-19. RECENT FINDINGS: Evidence to date does not suggest that people living with HIV (PLWH) have a markedly higher susceptibility to SARS-CoV-2 infection, with disparities in the social determinants of health and comorbidities likely having a greater influence. The majority of literature has not supported a higher risk for severe disease among PLWH in Europe and the United States, although a large, population-based study in South Africa reported a higher rate of death due to COVID-19. Higher rates of comorbidities associated with COVID-19 disease severity among PLWH is an urgent concern. COVID-19 is leading to decreased access to HIV prevention services and HIV testing, and worsening HIV treatment access and virologic suppression, which could lead to worsening HIV epidemic control. CONCLUSION: COVID-19 is threatening gains against the HIV epidemic, including the U.S. Ending the HIV Epidemic goals. The ongoing collision of these two global pandemics will continue to need both study and interventions to mitigate the effects of COVID-19 on HIV efforts worldwide.
PURPOSE OF REVIEW: We examine the interplay between the HIV and COVID-19 epidemics, including the impact of HIV on COVID-19 susceptibility and severe disease, the effect of the COVID-19 epidemic on HIV prevention and treatment, and the influence of the HIV epidemic on responses to COVID-19. RECENT FINDINGS: Evidence to date does not suggest that people living with HIV (PLWH) have a markedly higher susceptibility to SARS-CoV-2 infection, with disparities in the social determinants of health and comorbidities likely having a greater influence. The majority of literature has not supported a higher risk for severe disease among PLWH in Europe and the United States, although a large, population-based study in South Africa reported a higher rate of death due to COVID-19. Higher rates of comorbidities associated with COVID-19 disease severity among PLWH is an urgent concern. COVID-19 is leading to decreased access to HIV prevention services and HIV testing, and worsening HIV treatment access and virologic suppression, which could lead to worsening HIV epidemic control. CONCLUSION: COVID-19 is threatening gains against the HIV epidemic, including the U.S. Ending the HIV Epidemic goals. The ongoing collision of these two global pandemics will continue to need both study and interventions to mitigate the effects of COVID-19 on HIV efforts worldwide.
Authors: Emily C Williams; Kathleen A McGinnis; Janet P Tate; Theresa E Matson; Anna D Rubinsky; Jennifer F Bobb; Gwen T Lapham; E Jennifer Edelman; Sheryl L Catz; Derek D Satre; Kendall J Bryant; Brandon D L Marshall; Kevin L Kraemer; Kara M Bensley; Julie E Richards; Melissa Skanderson; Amy C Justice; David A Fiellin; Katharine A Bradley Journal: J Acquir Immune Defic Syndr Date: 2019-08-01 Impact factor: 3.731
Authors: Christian Schoergenhofer; Bernd Jilma; Thomas Stimpfl; Mario Karolyi; Alexander Zoufaly Journal: Ann Intern Med Date: 2020-05-12 Impact factor: 25.391
Authors: Glenn-Milo Santos; Benjamin Ackerman; Amrita Rao; Sara Wallach; George Ayala; Erik Lamontage; Alex Garner; Ian W Holloway; Sonya Arreola; Vince Silenzio; Susanne Strömdahl; Louis Yu; Carol Strong; Tyler Adamson; Anna Yakusik; Tran Thu Doan; Poyao Huang; Damiano Cerasuolo; Amie Bishop; Teymur Noori; Anastasia Pharris; Max Aung; Masoud Dara; Ssu Yu Chung; Marguerite Hanley; Stefan Baral; Chris Beyrer; Sean Howell Journal: AIDS Behav Date: 2021-02
Authors: Eric A Meyerowitz; Arthur Y Kim; Kevin L Ard; Nesli Basgoz; Jacqueline T Chu; Rocio M Hurtado; Catherine K Lee; Wei He; Theresa Minukas; Sandra Nelson; Bisola O Ojikutu; Greg Robbins; Sarimer Sanchez; Virginia A Triant; Kimon Zachary; Rajesh T Gandhi Journal: AIDS Date: 2020-10-01 Impact factor: 4.632
Authors: Matthew S Durstenfeld; Kaiwen Sun; Yifei Ma; Fatima Rodriguez; Eric A Secemsky; Rushi V Parikh; Priscilla Y Hsue Journal: AIDS Date: 2022-03-01 Impact factor: 4.177
Authors: Rachel A Bender Ignacio; Adrienne E Shapiro; Robin M Nance; Bridget M Whitney; Joseph A C Delaney; Laura Bamford; Darcy Wooten; Maile Y Karris; William C Mathews; Hyang Nina Kim; Jeanne Keruly; Greer Burkholder; Sonia Napravnik; Kenneth H Mayer; Jeffrey Jacobson; Michael Saag; Richard D Moore; Joseph J Eron; Amanda L Willig; Katerina A Christopoulos; Jeffrey Martin; Peter W Hunt; Heidi M Crane; Mari M Kitahata; Edward R Cachay Journal: AIDS Date: 2022-05-06 Impact factor: 4.632
Authors: Rupert Kaul; Cindy M Liu; Daniel E Park; Ronald M Galiwango; Aaron A R Tobian; Jessica L Prodger Journal: Viruses Date: 2022-05-27 Impact factor: 5.818
Authors: Matthew A Spinelli; Lillian B Brown; David V Glidden; Kyle Hunter; Patrick Martin-Tuite; James Zheng; Curtis Sera; Diane Havlir; Susan P Buchbinder; Monica Gandhi Journal: AIDS Date: 2021-12-01 Impact factor: 4.177
Authors: Catherine Riou; Elsa du Bruyn; Cari Stek; Remy Daroowala; Rene T Goliath; Fatima Abrahams; Qonita Said-Hartley; Brian W Allwood; Nei-Yuan Hsiao; Katalin A Wilkinson; Cecilia S Lindestam Arlehamn; Alessandro Sette; Sean Wasserman; Robert J Wilkinson Journal: J Clin Invest Date: 2021-06-15 Impact factor: 14.808
Authors: Matthew S Durstenfeld; Kaiwen Sun; Yifei Ma; Fatima Rodriguez; Eric A Secemsky; Rushi V Parikh; Priscilla Y Hsue Journal: medRxiv Date: 2021-04-07
Authors: Matthew A Spinelli; Kara L Lynch; Cassandra Yun; David V Glidden; Michael J Peluso; Timothy J Henrich; Monica Gandhi; Lillian B Brown Journal: Lancet HIV Date: 2021-04-29 Impact factor: 12.767